Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations.

Kühtreiber WM, Tran L, Kim T, Dybala M, Nguyen B, Plager S, Huang D, Janes S, Defusco A, Baum D, Zheng H, Faustman DL.

NPJ Vaccines. 2018 Jun 21;3:23. doi: 10.1038/s41541-018-0062-8. eCollection 2018.

2.

Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis.

Lachmandas E, Thiem K, van den Heuvel C, Hijmans A, de Galan BE, Tack CJ, Netea MG, van Crevel R, van Diepen JA.

Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):371-380. doi: 10.1007/s10096-017-3145-y. Epub 2017 Nov 30.

3.

TNF, TNF inducers, and TNFR2 agonists: A new path to type 1 diabetes treatment.

Faustman DL.

Diabetes Metab Res Rev. 2018 Jan;34(1). doi: 10.1002/dmrr.2941. Epub 2017 Sep 29. Review.

PMID:
28843039
4.

Robust immunoreactivity of teenager sera against peptide 19 from Porphyromonas gingivalis HSP60.

Kwon EY, Cha GS, Joo JY, Lee JY, Choi J.

J Periodontal Implant Sci. 2017 Jun;47(3):174-181. doi: 10.5051/jpis.2017.47.3.174. Epub 2017 Jun 28.

5.

Prevalence of pulmonary tuberculosis in young adult patients with Type 1 diabetes mellitus in India.

Nair A, Guleria R, Kandasamy D, Sharma R, Tandon N, Singh UB, Goswami R.

Multidiscip Respir Med. 2016 May 10;11:22. doi: 10.1186/s40248-016-0058-z. eCollection 2016.

6.

Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, Ouachée-Chardin M, Fouyssac F, Girisha KM, Etzioni A, Van Montfrans J, Camcioglu Y, Kerns LA, Belohradsky B, Blanche S, Bousfiha A, Rodriguez-Gallego C, Meyts I, Kisand K, Reichenbach J, Renner ED, Rosenzweig S, Grimbacher B, van de Veerdonk FL, Traidl-Hoffmann C, Picard C, Marodi L, Morio T, Kobayashi M, Lilic D, Milner JD, Holland S, Casanova JL, Puel A; International STAT1 Gain-of-Function Study Group.

Blood. 2016 Jun 23;127(25):3154-64. doi: 10.1182/blood-2015-11-679902. Epub 2016 Apr 25.

7.

Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.

Kumar NP, Sridhar R, Nair D, Banurekha VV, Nutman TB, Babu S.

Immunology. 2015 Apr;144(4):677-86. doi: 10.1111/imm.12421.

8.

Impact of diabetes on the natural history of tuberculosis.

Restrepo BI, Schlesinger LS.

Diabetes Res Clin Pract. 2014 Nov;106(2):191-9. doi: 10.1016/j.diabres.2014.06.011. Epub 2014 Jul 14. Review.

9.

[Papilledema secondary to tuberculous meningitis in a patient with type 1 diabetes mellitus].

Caire Estévez JP, González-Ocampo Dorta S, Sanz Solana P.

Arch Soc Esp Oftalmol. 2013 Oct;88(10):403-6. doi: 10.1016/j.oftal.2012.05.010. Epub 2012 Jul 20. Spanish.

PMID:
24060305
10.

New onset diabetes in a patient with active tuberculosis.

Skowroński M, Halicka A, Barinow-Wojewódzki A.

Pneumonol Alergol Pol. 2012;80(5):467-70.

11.

[Intranasal vaccination with mycobacterial 65-kD heat-shock protein can prevent insulitis and diabetes in non-obese diabetic mice].

Zhu AH, Jin L, Liu JJ, Liu MY, Lv AJ, Zheng YL.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Nov;27(11):1165-8. Chinese.

PMID:
22078438
12.

NKT cells are required for complete Freund's adjuvant-mediated protection from autoimmune diabetes.

Lee IF, van den Elzen P, Tan R, Priatel JJ.

J Immunol. 2011 Sep 15;187(6):2898-904. doi: 10.4049/jimmunol.1002551. Epub 2011 Aug 15.

13.

Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes.

Nikoopour E, Schwartz JA, Huszarik K, Sandrock C, Krougly O, Lee-Chan E, Singh B.

J Immunol. 2010 May 1;184(9):4779-88. doi: 10.4049/jimmunol.0902822. Epub 2010 Apr 2.

14.

High prevalence of Mycobacterium tuberculosis infection and disease in children and adolescents with type 1 diabetes mellitus.

Webb EA, Hesseling AC, Schaaf HS, Gie RP, Lombard CJ, Spitaels A, Delport S, Marais BJ, Donald K, Hindmarsh P, Beyers N.

Int J Tuberc Lung Dis. 2009 Jul;13(7):868-74.

PMID:
19555537
15.

Higher susceptibility of type 1 diabetic rats to Mycobacterium tuberculosis infection.

Sugawara I, Mizuno S.

Tohoku J Exp Med. 2008 Dec;216(4):363-70.

16.

[Pulmonary tuberculosis and diabetes. A retrospective study of 60 patients in Tunisia].

Maâlej S, Belhaoui N, Bourguiba M, Mahouachi R, Chtourou A, Taktak S, Fennira H, Slim L, Kheder AB, Drira I.

Presse Med. 2009 Jan;38(1):20-4. doi: 10.1016/j.lpm.2008.05.011. Epub 2008 Sep 3. French.

PMID:
18771896
17.

[Improved efficacy of P277 fused to heat shock protein 65 of Mycobacterium tuberculosis against diabetes in nonobese diabetic mice].

Zhu A, Lu Y, Jin L, Wu J, Li T, Liu J.

Sheng Wu Gong Cheng Xue Bao. 2008 Apr;24(4):640-5. Chinese.

PMID:
18616176
18.

Potential health effects from non-specific stimulation of the immune function in early age: the example of BCG vaccination.

Rousseau MC, Parent ME, St-Pierre Y.

Pediatr Allergy Immunol. 2008 Aug;19(5):438-48. doi: 10.1111/j.1399-3038.2007.00669.x. Epub 2007 Dec 27. Review.

PMID:
18167158
19.

Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression.

Santos Júnior RR, Sartori A, Bonato VL, Coelho Castelo AA, Vilella CA, Zollner RL, Silva CL.

Clin Exp Immunol. 2007 Sep;149(3):570-8. Epub 2007 Jun 22.

20.

[Regulatory T cells].

Marinić I, Gagro A, Rabatić S.

Acta Med Croatica. 2006 Dec;60(5):447-56. Review. Croatian.

PMID:
17217101

Supplemental Content

Loading ...
Support Center